Table 2.
Pre-injection vs. final follow-up in 13 weeks: intragroup analysis
Variable | Pre-injection (n=24) | Final follow-up (n=24) | P-value* |
---|---|---|---|
GH group (n=24) | |||
FE ROM (°) | 127.5±7.4 | 148.8±3.4 | <0.001 |
ER at side ROM (°) | 53.8±13.1 | 76.9±13.0 | <0.001 |
IR at 90° ROM (°) | 45.4±7.2 | 75.0±11.5 | <0.001 |
pVAS score | 6.3±2.0 | 2.6±2.1 | <0.001 |
ASES score | 46.1±18.4 | 74.5±19.0 | <0.001 |
Constant score | 55.9±7.9 | 67.2±8.8 | <0.001 |
SA group (n=24) | |||
FE ROM (°) | 129.2±8.3 | 148.3±3.8 | <0.001 |
ER at side ROM (°) | 54.6±10.8 | 76.5±8.0 | <0.001 |
IR at 90° ROM (°) | 48.8±9.0 | 74.4±8.9 | <0.001 |
pVAS score | 6.0±1.2 | 2.6±1.5 | <0.001 |
ASES score | 53.0±8.9 | 77.1±12.9 | <0.001 |
Constant score | 59.2±7.6 | 68.7±9.9 | <0.001 |
Values are presented as mean±standard deviation. GH group: ultrasound-guided glenohumeral steroid injection, SA group: ultrasound-guided subacromial steroid injection.
FE: forward elevation, ROM: range of motion, ER: external rotation at side, IR: internal rotation at 90˚ of abduction, pVAS: pain visual analog scale, ASES: American Shoulder and Elbow Surgeons, Constant: Constant-Murley.
P-value <0.05.